JB Chemicals & Pharmaceuticals

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue600.66624.59784.81809.44792.71
Expenses489.52521.77638.13652.99646.34
EBITDA111.14102.82146.68156.45146.37
EBIT94.1780.71120.60128.32117.97
Profit Before Tax114.33103.28141.74149.83141.20
Net Profit83.8984.85105.03111.08106.10
Financial Ratios
Operating Profit Margin18.50%16.46%18.69%19.33%18.46%
Net Profit Margin13.97%13.58%13.38%13.72%13.38%
Earning Per Share (Diluted)10.8510.9713.4814.2613.57
Dividends Per ShareNA8.00NANA8.50
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.7.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI